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Background: Type 2 diabetes (T2DM) is the most common form of diabetes.  
Obesity is associated with both the development of T2DM and also the 
development of the complications of diabetes; increasing health care costs and 
morbidity and mortality.  Weight loss and control of blood glucose levels should be 
managed with a tailored eating plan developed in negotiation between the person 
with diabetes and their health care team.  It is essential that health care 
professionals are familiar with different strategies that achieve weight reduction, 
glycaemic and cardiovascular risk reduction goals.  One emerging weight reduction 
strategy is fasting diets.  There is currently a gap in the knowledge of whether 
fasting diets are an effective and safe weight reduction strategy for people with 
T2DM on insulin.   
 
Aim: To investigate the effectiveness and safety of an intermittent fasting diet (two 
day per week) as an alternative to standard dietary advice (portion control diet) for 
weight reduction in obese adults with insulin dependent T2DM attending a 12-week 
group based intervention at Waitemata District Health Board (DHB). 
 
Methods: 
Obese patients with T2DM treated with insulin who were attending Waitemata 
DHB Diabetes Service were recruited for this two arm open-label design 
intervention feasibility study.  Both dietary strategies were implemented during a 
12-week intervention at which participants received monthly dietitian-led group 
education and support.  The intermittent fasting diet (IFD) intervention (n=8) 
investigated was a two day per week reduced energy intake (550-650kcal / 2300-
2700kJ per day) and five days’ usual intake making low fat choices.  The portion 
control diet (PCD) was the comparison group (n=7) and focused on daily energy 
restriction through reduction in portion sizes and low fat food choices in line with 




Results: Similar weight loss was achieved in both groups (IFD: 2.7 ± 3.0 kg, PCD:      
1.7 ± 2.5 kg). This reduction was not significant between groups.  There was a 
significant difference between groups in reduction in HbA1c. (P=0.003) (IFD:              
-11 mmol/mol, PCD: -3 mmol/mol). This decrease was significant in the IFD group 
only (P=0.018).  Reported hypoglycaemic events were low in both groups (8 events 
in IFD; 21 events in PCD). Non-significant between group reductions in waist 
circumference (P=0.402), waist: height ratio (P=0.455), diastolic (P=0.189) and 
systolic blood pressure (P=0.443) were observed.  Lipid profile remained stable in 
both groups.   
 
Conclusion: This feasibility study showed that an intermittent fasting diet can 
achieve similar weight loss to current standard practice dietary advice in people 
with T2DM.  However, it is the significant reductions in HbA1c compared to a daily 
energy restriction diet over a three-month period seen in this study that warrant 
further investigation.  With education from health care professionals and 
modification of insulin on pre-fasting and fasting day this diet may be followed 






There is a story behind this thesis which may help to put in to context the practical 
nature of this research.  Bear with me.  Thirty years ago this year (2016) I was 
diagnosed with Type 1 Diabetes.  Aged 13 and within five days of my diagnosis I had 
mapped out my career as a Dietitian.  This year is also the 22nd anniversary of 
graduating from Queen Margaret College (now University), Edinburgh with a 
Bachelor of Science degree in Dietetics.  When I was diagnosed with diabetes I was 
fortunate that neither my parents nor health care team put restrictions on what I 
could or could not achieve.  I feel fortunate that I have travelled the world, had 
many adventures, run many half-marathons, and have two wonderful daughters, a 
husband and my health.  So, when faced with people who try and tell me that I 
can’t do something just because I have diabetes I don’t often believe them.  And 
this is the case with this research.  I still have the original Radio Times magazine 
article about a Horizon documentary that my mother sent me from Scotland.  The 
documentary was about a Doctor, a health journalist, who investigated intermittent 
fasting because he had been diagnosed with pre-diabetes.  Mum wanted to know 
my opinion.  In my investigations I came across many people telling me that people 
with diabetes on insulin shouldn’t fast.  Yet I knew that personally I had fasted 
safely, and professionally I had worked with people who had fasted.  Meanwhile, in 
an office at the hospital I worked at, Dr Catherine McNamara, Consultant 
Endocrinologist had also heard about intermittent fasting.  More than that, she had 
read the book and the research and was intrigued as to whether it would be of 
benefit to her patients with Type 2 Diabetes who needed to lose weight.  People 
were asking about this diet in clinics.  Together we came up with the research study 
that is presented here as my MSc thesis.  Living and working with diabetes there is 
one thing that has come up time and time again, and that is there are no set rules 
when it comes to diabetes.  Trying to fit the condition(s) that are labelled as 
diabetes in to neat boxes does not work, because blood glucose is affected by so 
many things.  People with diabetes tend to have multiple diagnoses and multiple 
stresses.  It was important to keep this research as practical and “real life” as 
possible, whilst making sure that the results were still meaningful.  It seems fitting 
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that my dietetic career started with a diagnosis of diabetes, and here I am 
concluding my academic studies with research to help people with diabetes.   
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effort, brain-power and emotion.  Adding a dietary intervention that is slightly out 
of the box on top of that, I am very grateful for you for spending that extra time and 
effort to take part in this dietary intervention.  Thank you to the staff at the 
Diabetes Service, Waitemata District Health Board for your support, advice and 
enthusiasm in helping to recruit and run this study.  Especially Eirean Gamble, 
Diabetes Dietitian Team Leader whose feedback and support was invaluable, and Dr 
Catherine McNamara, Consultant Endocrinologist who identified the need for this 
study and provided medical support and input to the study.   
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Kruger for their support, advice, feedback and expertise during this process.   
 
Thanks to Dietitians New Zealand for awarding me the Neige Todhunter Award in 
2014.  This award provided the financial assistance to allow me to complete this 
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